U.O. Pneumologia, Azienda Ospedaliera "Misericordia", Grosseto, Italy.
Eur Rev Med Pharmacol Sci. 2010 May;14(5):487-90.
The pandemic influenza A H1N1 will affect millions of subjects. This influenza can cause respiratory complications with possible death. We have described two case reports of acute severe asthma exacerbation combined to influenza A H1N1, caracterized by severe respiratory failure. The diagnosis of influenza A H1N1 was confirmed with the multiplex reverse transcription-polymerase chain reaction (RT-PCR) assay. These patients, apart from asthma, do not have other diseases; but they did not take adequate therapy. In addition to conventional therapy (corticosteroids, bronchodilator and antibiotics) oseltamivir 75 mg bid was immediately added. After few days the patients improved and therefore in a short time they were discharged. During this period, in the case of severe asthma exacerbations, one must always think of influenza A H1N1 as the possible cause. It is necessary to use oseltamivir precociously to avoid severe complications. All asthmatic patients must regularly take their therapy especially during pandemic influenza A H1N1.
甲型 H1N1 流感大流行将影响数百万人。这种流感可导致呼吸道并发症,甚至可能导致死亡。我们描述了两例甲型 H1N1 流感合并急性严重哮喘发作的病例报告,其特征为严重呼吸衰竭。甲型 H1N1 的诊断通过多重逆转录聚合酶链反应 (RT-PCR) 检测得到确认。这些患者除了哮喘外没有其他疾病,但没有接受足够的治疗。除了常规治疗(皮质类固醇、支气管扩张剂和抗生素)外,还立即加用奥司他韦 75mg bid。数天后患者病情改善,因此很快出院。在此期间,对于严重哮喘发作,必须始终考虑甲型 H1N1 流感可能是病因。必须及早使用奥司他韦以避免严重并发症。所有哮喘患者在大流行期间必须定期服药,特别是在甲型 H1N1 流感期间。